Skip to content
August 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Recalculating: Navigating the Uncharted Territory of a Cancer Diagnosis recalculating-navigating-the-uncharted-territory-of-a-cancer-diagnosis
  • Survivorship and Post-Treatment

Recalculating: Navigating the Uncharted Territory of a Cancer Diagnosis

Nana Wu July 30, 2026
By Investigative Health Desk April 16, 2026 The journey through a cancer diagnosis is rarely a straight...
Read More Read more about Recalculating: Navigating the Uncharted Territory of a Cancer Diagnosis
Beyond the Parade: How Richard Goldman’s Journey of Resilience Redefines the Spirit of Pride beyond-the-parade-how-richard-goldmans-journey-of-resilience-redefines-the-spirit-of-pride
  • Integrative Oncology and Holistic Care

Beyond the Parade: How Richard Goldman’s Journey of Resilience Redefines the Spirit of Pride

Azzam Bilal Chamdy July 30, 2026
Introduction: The Enduring Legacy of Compassion Pride is often distilled into images of vibrant parades, colorful floats,...
Read More Read more about Beyond the Parade: How Richard Goldman’s Journey of Resilience Redefines the Spirit of Pride
The Battle Over the Abortion Pill: Public Confusion, Political Polarization, and the Future of Mifepristone the-battle-over-the-abortion-pill-public-confusion-political-polarization-and-the-future-of-mifepristone
  • Breast Cancer Legislation and Policy

The Battle Over the Abortion Pill: Public Confusion, Political Polarization, and the Future of Mifepristone

Asep Darmawan July 30, 2026
The landscape of reproductive healthcare in the United States has shifted dramatically in the wake of the...
Read More Read more about The Battle Over the Abortion Pill: Public Confusion, Political Polarization, and the Future of Mifepristone
Data as a Lifeline: METAvivor Urges Congress to Bolster National Cancer Registries for 2027 data-as-a-lifeline-metavivor-urges-congress-to-bolster-national-cancer-registries-for-2027
  • Metastatic Breast Cancer Research

Data as a Lifeline: METAvivor Urges Congress to Bolster National Cancer Registries for 2027

Asro July 30, 2026
In the high-stakes battle against cancer, data is not merely a collection of statistics—it is the frontline...
Read More Read more about Data as a Lifeline: METAvivor Urges Congress to Bolster National Cancer Registries for 2027
The Subtle Art of Stillness: Deciphering the Kneeling Triad of Yoga the-subtle-art-of-stillness-deciphering-the-kneeling-triad-of-yoga
  • Integrative Oncology and Holistic Care

The Subtle Art of Stillness: Deciphering the Kneeling Triad of Yoga

Raul Delapena Setiawan July 30, 2026
Published July 28, 2026 In the modern yoga studio, the sequence of movement is often fluid, punctuated...
Read More Read more about The Subtle Art of Stillness: Deciphering the Kneeling Triad of Yoga
Innovation at the Intersection of Science: A Preview of AAPS PharmSci 360 2026 innovation-at-the-intersection-of-science-a-preview-of-aaps-pharmsci-360-2026
  • Treatment Innovations

Innovation at the Intersection of Science: A Preview of AAPS PharmSci 360 2026

Nana Wu July 30, 2026
The pharmaceutical industry stands at a critical juncture, where the convergence of advanced computational modeling, artificial intelligence...
Read More Read more about Innovation at the Intersection of Science: A Preview of AAPS PharmSci 360 2026
Beyond the Operating Room: How Food Deserts Impact Breast Reconstruction Outcomes beyond-the-operating-room-how-food-deserts-impact-breast-reconstruction-outcomes
  • Breast Cancer Surgery and Reconstruction

Beyond the Operating Room: How Food Deserts Impact Breast Reconstruction Outcomes

Muslim July 30, 2026
In the complex landscape of post-mastectomy recovery, the focus has traditionally remained on surgical technique, anesthesia protocols,...
Read More Read more about Beyond the Operating Room: How Food Deserts Impact Breast Reconstruction Outcomes
CoreMap Secures $37M in Series C Funding to Revolutionize Atrial Fibrillation Mapping coremap-secures-37m-in-series-c-funding-to-revolutionize-atrial-fibrillation-mapping
  • Treatment Innovations

CoreMap Secures $37M in Series C Funding to Revolutionize Atrial Fibrillation Mapping

Asep Darmawan July 30, 2026
In a significant move for the cardiovascular medtech sector, Massachusetts-based CoreMap has successfully closed a $37 million...
Read More Read more about CoreMap Secures $37M in Series C Funding to Revolutionize Atrial Fibrillation Mapping
Turning the Tide: WHO Unveils ‘PROTECT’ Strategy to Combat the Silent Epidemic of Drowning turning-the-tide-who-unveils-protect-strategy-to-combat-the-silent-epidemic-of-drowning
  • Breast Cancer Prevention and Lifestyle

Turning the Tide: WHO Unveils ‘PROTECT’ Strategy to Combat the Silent Epidemic of Drowning

Ammar Sabilarrohman July 30, 2026
As the global community prepares to observe World Drowning Prevention Day on July 25, the World Health...
Read More Read more about Turning the Tide: WHO Unveils ‘PROTECT’ Strategy to Combat the Silent Epidemic of Drowning
FDA Approves Gedatolisib (Revtorpyk) for Advanced HR-Positive/HER2-Negative Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance fda-approves-gedatolisib-revtorpyk-for-advanced-hr-positive-her2-negative-breast-cancer-a-new-paradigm-in-overcoming-endocrine-resistance
  • Patient Advocacy and Support

FDA Approves Gedatolisib (Revtorpyk) for Advanced HR-Positive/HER2-Negative Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance

Asro July 30, 2026
The landscape of metastatic breast cancer treatment has undergone a significant transformation with the recent U.S. Food...
Read More Read more about FDA Approves Gedatolisib (Revtorpyk) for Advanced HR-Positive/HER2-Negative Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance

Posts pagination

Previous 1 … 41 42 43 44 45 46 47 … 418 Next

Recent Posts

  • The Transformation of U.S. Global Health: Assessing the Impact of Executive Restructuring
  • Bridging the Gap in Cancer Research: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act
  • Groundbreaking UMass Chan Research Redefines How Cancer Drugs Kill BRCA Mutant Cells, Offering New Hope Against Drug Resistance
  • Dispatch Bio Advances Promising Immunotherapy for Advanced GI Cancers with First Patient Dosed in Phase I Trial
  • The Dismantling of U.S. Global Health: Assessing the Impact of the New Executive Mandates

Recent Comments

No comments to show.

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

the-transformation-of-u-s-global-health-assessing-the-impact-of-executive-restructuring
  • Breast Cancer Legislation and Policy

The Transformation of U.S. Global Health: Assessing the Impact of Executive Restructuring

Nana Wu August 8, 2026
bridging-the-gap-in-cancer-research-metavivor-joins-coalition-to-champion-the-clinical-trial-modernization-act
  • Patient Advocacy and Support

Bridging the Gap in Cancer Research: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act

Muslim August 8, 2026
groundbreaking-umass-chan-research-redefines-how-cancer-drugs-kill-brca-mutant-cells-offering-new-hope-against-drug-resistance
  • Medical Research and Clinical Trials

Groundbreaking UMass Chan Research Redefines How Cancer Drugs Kill BRCA Mutant Cells, Offering New Hope Against Drug Resistance

Lina Hope August 8, 2026
dispatch-bio-advances-promising-immunotherapy-for-advanced-gi-cancers-with-first-patient-dosed-in-phase-i-trial
  • Medical Research and Clinical Trials

Dispatch Bio Advances Promising Immunotherapy for Advanced GI Cancers with First Patient Dosed in Phase I Trial

Suro Senen August 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.